Our research is designed to explain trends and inequalities in cancer survival at regional, national and international level, including in socio-economic, racial and ethnic groups of the population. The results help policy-makers to target investment in cancer services to improve survival and reduce inequalities. The core target in the national cancer plan for England – to reduce avoidable cancer deaths by 5,000 a year, is based on our research comparing survival trends in Britain with trends in other European countries. We also develop new methods for cancer survival analysis, as part of the CENSUR group.
Socio-economic inequalities in cancer survival in England have fallen only slightly since the NHS Cancer Plan of 2000: this has important policy implications for earlier diagnosis and more rapid access to optimal treatment for all groups of society. The EUROCARE-5 study showed that survival for cancer patients diagnosed up to 2007 in the UK has remained lower than in many other European countries, although the differences are becoming less marked for some cancers. We have reported regional differences in survival within the UK. In collaboration with 279 cancer registries, we recently reported huge world-wide differences in cancer survival among over 25 million cancer patients in 67 countries (CONCORD-2).
Our annual short course on Cancer Survival: Principles, Methods and Applications has been running for ten years: details for 2017 here. Participants based in low-, lower-middle and upper-middle income countries [LMIC] are entitled to a special discounted fee.
Together with the Office for National Statistics (ONS), we have published the official National Statistics on cancer survival in England every year since 2000, as well as the NHS Outcome Framework indicators on cancer survival for the 211 Clinical Commissioning Groups. We recently published survival figures for all childhood cancers combined.
We have shown that half of all people diagnosed in England and Wales can now expect to survive from their cancer for at least 10 years, compared to just 25% 40 years ago. Cancer Research UK launched its new research strategy in 2014 on the basis of these results. For more information please follow this link.